Product
Candesartan Cilexetil
Name
CANDESARTAN CILEXETIL
INN Name
CANDESARTAN CILEXETIL
FDA Approved
Yes
2 clinical trials
1 organization
2 indications
1 document
Indication
COVID-19Indication
Traumatic Brain InjuryClinical trial
An Investigator Initiated, International Multi-Centre, Multi-Arm, Multi-Stage Randomised Double Blind Placebo Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19Status: Terminated, Estimated PCD: 2022-08-15
Clinical trial
Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain InjuryStatus: Not yet recruiting, Estimated PCD: 2028-08-31
Organization
Alembic Pharmaceuticals Inc.